Thomas Scheidmeir
Vorstandsvorsitzender bei AbbVie Deutschland GmbH & Co. KG
Aktive Positionen von Thomas Scheidmeir
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
AbbVie Deutschland GmbH & Co. KG
 AbbVie Deutschland GmbH & Co. KG BiotechnologyHealth Technology Part of AbbVie, Inc., AbbVie Deutschland GmbH & Co. KG is a German company that focuses on treating plaque psoriasis, a chronic inflammatory skin disease that cannot be cured but can be managed effectively. The company is based in Wiesbaden, Germany. The CEOs of the company are Thomas Scheidmeir, Stefan Simianer. | Vorstandsvorsitzender | - | - |
AbbVie Pharmaceuticals GmbH
 AbbVie Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., AbbVie Pharmaceuticals GmbH is a German pharmaceutical company that manufactures pharmaceuticals. The company is based in Hannover, Germany. The CEO of the company is Patrick Horber. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Thomas Scheidmeir
Statistik
International
| Deutschland | 3 |
Operativ
| Chief Executive Officer | 1 |
| Director/Board Member | 1 |
Sektoral
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
AbbVie Deutschland GmbH & Co. KG
AbbVie Deutschland GmbH & Co. KG BiotechnologyHealth Technology Part of AbbVie, Inc., AbbVie Deutschland GmbH & Co. KG is a German company that focuses on treating plaque psoriasis, a chronic inflammatory skin disease that cannot be cured but can be managed effectively. The company is based in Wiesbaden, Germany. The CEOs of the company are Thomas Scheidmeir, Stefan Simianer. | Health Technology |
AbbVie Pharmaceuticals GmbH
AbbVie Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., AbbVie Pharmaceuticals GmbH is a German pharmaceutical company that manufactures pharmaceuticals. The company is based in Hannover, Germany. The CEO of the company is Patrick Horber. | Health Technology |
- Börse
- Insiders
- Thomas Scheidmeir
- Erfahrung
